Thrombin induces broad spectrum proteolysis in human serum samples

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 6, 2009, Pages 685-693

  O'Mullan, Patrick ^a   Craft, David ^a   Yi, Jizu ^a   Gelfand, Craig A ^a  

^a BD Technologies   (United States)

Author keywords

Fibrinopeptide; Proteolysis; Thrombin

Indexed keywords

FIBRINOGEN; FIBRINOPEPTIDE A; HEMOPEXIN; PLASMA PROTEIN; THROMBIN;

ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CONTROLLED STUDY; HEATING; HUMAN; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE ANALYSIS; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DENATURATION; PROTEIN FUNCTION; PROTEIN VARIANT; SERUM;

AMINO ACID SEQUENCE; BLOOD COAGULATION; FIBRINOGEN; FIBRINOPEPTIDE A; HEMOPEXIN; HOT TEMPERATURE; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PLASMA; PROTEASE INHIBITORS; PROTEIN STABILITY; PROTEOMICS; SERUM; SPECIMEN HANDLING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; THROMBIN;

EID: 67650624097     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.003     Document Type: Article

References (35)

1. Anderson NL, Polanski M, Pieper R, Gatlin T, Tirumalai RS, Conrads TP, et al. The human plasma proteome. Mol Cell Proteomics 2004;3:311-26.
2. Dailey JF. Dailey's notes on blood, 3rd ed. Arlington, MA: Medical Consulting Group, 1996.
3. Baumann S, Ceglarek U, Fiedler GM, Lembcke J, Leichtle A, Thiery J. Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 2005;51:973-80.
4. Harris JL, Backes BJ, Leonetti F, Mahrus S, Ellman JA, Craik CS. Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. Proc Natl Acad Sci USA 2000;97:7754-9.
5. Barrett AJ, Rawlings ND, Woessner JF, editors. Handbook of proteolytic enzymes, 2nd ed. (vol. 1, 2). London, UK: Elsevier Academic Press, 2004.
6. Blomback B, Hessel B, Iwanaga S, Reuterby J, Blomback M. Primary structure of human fibrinogen and fibrin. J Biol Chem 1972;247:1496-512.
7. Lorand L. Sol Sherry lecture on thrombosis; research on clot stabilization provides clues for improving thrombo-lytic therapies. Arterioscler Thromb Vasc Biol 2000;20: 2-9.
8. Albrethsen J, Bøgebo R, Olsen J, Raskov H, Gammeltoft S. Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum. Clin Chem Lab Med 2006; 44:1243-52.
9. Banks RE, Stanley AJ, Cairns DA, Barrett JH, Clarke P, Thompson D, et al. Influences of blood sample processing on low-molecular-weight proteome identification by surface-enhanced laser desorption/ionization mass spec-trometry. Clin Chem 2005;51:1637-49.
10. Koomen JM, Li D, Xiao LC, Liu TC, Coombes KR, Abbruz-zese J, et al. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. J Proteome Res 2005;4:972-81.
11. Timms JF, Arslan-Low E, Gentry-Maharaj A, Luo Z, T'Jampens D, Podust VN, et al. Preanalytical influence of sample handling on SELDI-TOF serum protein profiles. Clin Chem 2007;53:645-56.
12. Rai AJ, Gelfand CA, Haywood BC, Warunek DJ, Yi J, Schuchard MD, et al. HUPO plasma proteome project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 2005;5:3262-77.
13. Quek HH, Finnochio TM, Gelfand CA. Comparative analysis of cytokines in human blood plasma and serum using protein microarrays. US HUPO Meeting, Washington, DC, USA, 2005.
14. Villanueva J, Martorella AJ, Lawlor, K. Philip J, Fleisher M, Robbins RJ, et al. Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age. Mol Cell Pro-teomics 2006;5:1840-52.
15. Villanueva J, Shaffer DR, Phiip J, Chapparro CA, Erdju-ment-Bromage H, Olshen AB, et al. Differential exopro-tease activities confer tumor-specific serum peptidome patterns. J Clin Invest 2006;116:271-84.
16. Yi J, Kim C, Gelfand CA. Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma. J Proteome Res 2007;6:1768-81.
17. Findeisen P, Sismanidis D, Riedl M, Costina V, Neumaier M. Preanalytical impact of sample handling on proteome profiling experiments with MALDI TOF MS. Clin Chem 2005;51:2409-11.
18. Malkovich R, Blaskó G, Ará nyi P. The interaction of thrombin and heparin. Heat inactivation kinetics. Thromb Res 1975;7:253-60.
19. Malkovich R, Aranyi P. Effect of calcium ion on the interaction between thrombin and heparin. Thermal denaturation. Thromb Haemost 1977;38:677-84.
20. Malkovich R, Aranyi P. Effect of heparin on thrombin inactivation by antithrombin-III. Biochem J 1978;173: 869-75.
21. Blombäck B, Blombäck M, Edman P, Hessel B. Human fibrinopeptides: isolation, characterization and structure. Biochim Biophys Acta 1966;115:371-96.
22. Di Cristofaro R, Castagnola M. Kinetic aspects of release of fibrinopeptides AP and AY by human alpha-thrombin. Haemostasis 1991;21:85-90.
23. Guasch MD, Plana M, Pena JM, Itarte E. Phosphorylation of fibrinogen by casein kinase 2. Biochem J 1986;234: 523-6.
24. Seydewitz HH, Witt I. Increased phosphorylation of human fibrinopeptide A under acute phase conditions. Thromb Res 1985;40:29-39.
25. Martin SC, Eckman P, Forsberg PO, Ersmark H. Increased phosphate content of fibrinogen in vivo correlates with alteration in fibrinogen behaviour. Thromb Res 1992; 68:467-73.
26. Seydewitz HH, Matthias FR, Schondorf TH, Witt I. Increase in the degree of phosphorylation of circulating fibrinogen under thrombolytic therapy with urokinase. Thromb Res 1987;46:437-45.
27. Southan C, Thompson E, Lane DA. Direct analysis of plasma fibrinogen-derived fibrinopeptides by high performance liquid chromatography: investigation of A alpha-chain N-terminal heterogeneity. Thromb Haemost 1986;56:93-197.
28. Andreatta RH, Liem RK, Scheraga HA. Mechanism of action of thrombin on fibrinogen, I. Synthesis of fibrin-ogen-like peptides, and their proteolysis by thrombin and trypsin. Proc Natl Acad Sci USA 1971;68:253-6.
29. Washburn MP, Wolters D, Yates JR, III. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001;9:242-7.
30. Mi Z, Oliver T, Guo H, Gao C, Kuo P. Thrombin cleaved COOH-terminal osteopontin peptide binds with cyclophilin C to CD147 in murine breast cancer cells. Cancer Res 2007;67:4088-97.
31. Kato T, Oda A, Inagaki Y, Ohashi H, Matsumoto A, Ozaki K, et al. Thrombin cleaves recombinant human thrombopoietin: one of the proteolytic events that generate truncated forms of thrombopoietin. Proc Natl Acad Sci USA 1997;94:4669-74.
32. Khurana S, Liby K, Buckley AR, Ben-Jonathan N. Proteo-lysis of human prolactin: resistance to cathepsin D and formation of a nonangiostatic, C-terminal 16K fragment by thrombin. Endocrinology 1999;140:4127-32.
33. Tirumalai RS, Chan KC, Prieto DA, Issaq HJ, Conrads TP, Veenstra TD. Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics 2003;2:1096-1103.
34. Roach LE, Petrik JJ, Plante L, LaMarre J, Gentry PA. Thrombin generation and the presence of thrombin receptor in ovarian follicles. Biol Reprod 2002;66:1350-8.
35. Findeisen P, Post S, Wenz F, Neumaier M. Addition of exogenous reporter peptides to serum samples before mass spectrometry based protease profiling provides advantages over profiling of endogenous peptides. Clin Chem 2007;53:1864-6.